Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
TERN - Terns Pharmaceuticals, Inc.
Market Cap 408.66M P/E - EPS this Y -8.70% Ern Qtrly Grth -
Income -90.21M Forward P/E -5.11 EPS next Y -2.90% 50D Avg Chg -25.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -22.00%
Dividend N/A Price/Book 1.42 EPS next 5Y - 52W High Chg -49.00%
Recommedations 2.10 Quick Ratio 22.06 Shares Outstanding 64.65M 52W Low Chg 276.00%
Insider Own 1.86% ROA -23.08% Shares Float 26.93M Beta -0.65
Inst Own 111.28% ROE -33.89% Shares Shorted/Prior 4.40M/4.23M Price 7.21
Gross Margin - Profit Margin - Avg. Volume 850,187 Target Price 14.21
Oper. Margin - Earnings Date May 13 Volume 280,719 Change 0.42%
Healthcare | Biotechnology | United States
About Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Terns Pharmaceuticals, Inc. News
04/14/24 Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans
04/10/24 Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
03/14/24 Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
03/11/24 Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
03/07/24 Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
02/27/24 Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
02/07/24 Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
02/07/24 Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
01/04/24 Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
11/29/23 Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
11/27/23 Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
11/14/23 Terns Pharmaceuticals Inc (TERN) Reports Q3 2023 Financials and Corporate Progress
11/14/23 Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates
11/13/23 Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023
11/09/23 Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
11/05/23 We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate
11/03/23 Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
11/02/23 Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity
10/19/23 Terns Pharmaceuticals to Participate in Upcoming Investor Conferences
10/16/23 Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia
TERN Chatroom

User Image Wallaby_Trantor Posted - 1 hour ago

$TERN That was a nice bounce.. 😮 Need a few more like that!

User Image PrecisionPlayz Posted - 6 hours ago

$TERN https://www.tipranks.com/news/blurbs/optimistic-buy-rating-for-terns-pharmaceuticals-based-on-tern-701-market-potential-and-strategy

User Image frogoracletrading Posted - 17 hours ago

$TERN Support / Resistance Levels Came down to retest the 4.40 support today and bounced hard. Here are the levels to watch. Needs to get back into and over the POC. Larger Image: https://s3.tradingview.com/snapshots/8/8WuVCMlI.png

User Image Target_Trader Posted - 20 hours ago

$TERN why are we constantly tanking wtf

User Image Mamatrader3 Posted - 21 hours ago

$TERN liking the fundamentals and financials here and the chart when is data expected ?

User Image Tenzen70 Posted - 21 hours ago

$TERN I am giving this one a ton of patience , not posted much and have not traded this either ( yes, traded a little on the few pops a bit ago ) However holding some size here. Technical trading and so forth is really time relevant and what your trade plan and time frame is. Mine here was longer from the get go. Technically so many things going on and nothing is really that clear however several thesis can be drawn ~ The chart needs a few more weeks to play out from current status. easy arguments for both sides (technically) I am a little bias to an easy organic 6.50-6.99 level without any catalyst

User Image Buysellbkr Posted - 23 hours ago

$TERN hovering at major support

User Image ScottyDoesntKnowMeSon Posted - 1 day ago

$TERN adding some down here. Like the Risk:Reward

User Image Tradelyfe Posted - 1 day ago

$TERN friends, when’s the catalyst expected here?

User Image Maverick44 Posted - 1 day ago

$TERN junk

User Image allgoodstill Posted - 1 day ago

$TERN Let’s TERN this to peanut butter.

User Image PrecisionPlayz Posted - 1 day ago

$TERN

User Image BioRich Posted - 1 day ago

@Remi5599 I agree but this has gotten squashed lately. Definitely didn't see this coming. I still believe $ADXN towers well over 30$ so may just average down. Feeling the same way with $TERN $TRVI and $SRPT. Believe in them big time but the short-term has been rough.

User Image kaan92 Posted - 1 day ago

$TERN will shine☀️❤️

User Image allgoodstill Posted - 2 days ago

$TERN Second half, fireworks.

User Image tradeXLNC Posted - 2 days ago

$TERN

User Image YouVSYou Posted - 2 days ago

$TERN Inverse H&S numerous time frames

User Image scoobydoo16 Posted - 2 days ago

$ALT $AUPH $BCRX $TERN $AKBA etc, etc, etc…….. What is this ”Patent Cliff” I hear so much about?

User Image Stokroulette Posted - 2 days ago

$IBRX average pretty untouchable here. I’ll hold this in my account until we reach our double digits . $TERN check out $MYSZ …. $MYSZ float so low , anything hits the tape she moves . Under 700 float . Are you kidding me 😱 😱. Put some buying pressure and let’s shoot this to the sky. Tell yo friend . Thin and ready . Just needs volume

User Image bavariaron Posted - 2 days ago

$TERN

User Image TU6637 Posted - 2 days ago

$TERN rise up ⬆️ 😎🤷‍♂️

User Image DonDeutsch Posted - 2 days ago

$TERN

User Image frogoracletrading Posted - 2 days ago

$TERN Support / Resistance Levels Nice push up to test 5 today. 4.60 is support for now. Larger Image: https://s3.tradingview.com/snapshots/c/CT2Iut8P.png

User Image Maverick44 Posted - 2 days ago

$TERN only red on my list today. Not shocking

User Image jlcrane Posted - 2 days ago

$TERN These beatdowns are outrageous!

User Image Blueskies3000 Posted - 2 days ago

$TERN taking a starter position with mttr profits

User Image Mocki87 Posted - 2 days ago

$TERN after a good Start-4% .. Chart looks Not good. Spy and nasdaq Green,

User Image tradeXLNC Posted - 2 days ago

@TU6637 $TERN reversal intact

User Image KiwiTraveller Posted - 2 days ago

$IBRX + $HOOK and still building into $TERN for my Bio plays atm

User Image tradeXLNC Posted - 2 days ago

$TERN #reversal intact, reclaim mid-$4 level for now, back into $5 imminent if volume continuation permits

Analyst Ratings
UBS Buy Mar 27, 24
JMP Securities Outperform Mar 18, 24
BMO Capital Outperform Mar 15, 24
HC Wainwright & Co. Neutral Mar 15, 24
HC Wainwright & Co. Neutral Jan 10, 24
JMP Securities Market Outperform Dec 5, 23
Mizuho Buy Nov 27, 23
HC Wainwright & Co. Neutral Aug 10, 23
JP Morgan Neutral Aug 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Yoon Seokho Bryan COO and General Coun.. COO and General Counsel Nov 30 Buy 3.78 743 2,809 18,399 12/04/23
Vignola Mark J. Chief Financial Offi.. Chief Financial Officer Nov 30 Buy 3.78 743 2,809 18,399 12/04/23
Yoon Seokho Bryan COO and General Coun.. COO and General Counsel Feb 01 Buy 1.41 3 4 7,659 02/03/23
Vignola Mark J. Chief Financial Offi.. Chief Financial Officer Feb 01 Buy 1.41 3 4 7,659 02/03/23
Sundaram Senthil Vel Chief Executive Offi.. Chief Executive Officer Feb 01 Buy 1.41 3 4 7,659 02/03/23
ORBIMED ADVISORS LLC Director Director Dec 23 Buy 7.25 137,931 1,000,000 4,882,854 12/28/22
GORDON CARL L Director Director Dec 23 Buy 7.25 137,931 1,000,000 4,882,854 12/28/22
Vivo Opportunity, LLC 10% Owner 10% Owner Dec 23 Buy 7.25 758,620 5,499,995 4,340,212 12/23/22
Lu Hongbo Director Director Dec 23 Buy 7.25 758,620 5,499,995 4,340,212 12/23/22
Vivo Opportunity, LLC 10% Owner 10% Owner Sep 07 Buy 3.60 600,000 2,160,000 3,581,592 09/08/22
Lu Hongbo Director Director Sep 07 Buy 3.60 600,000 2,160,000 3,581,592 09/08/22
ORBIMED ADVISORS LLC Director Director Aug 16 Buy 2.42 3,690,000 8,929,800 762,400 08/18/22
GORDON CARL L Director Director Aug 16 Buy 2.42 3,690,000 8,929,800 762,400 08/18/22
Vivo Opportunity, LLC 10% Owner 10% Owner Aug 12 Buy 2.8 2,624,239 7,347,869 2,981,592 08/16/22
Lu Hongbo Director Director Aug 12 Buy 2.8 2,624,239 7,347,869 2,981,592 08/16/22
Yoon Seokho Bryan COO and General Coun.. COO and General Counsel May 31 Buy 1.47 7,656 11,254 7,656 06/08/22
Vignola Mark J. Chief Financial Offi.. Chief Financial Officer May 31 Buy 1.47 7,656 11,254 7,656 06/08/22
Sundaram Senthil Vel Chief Executive Offi.. Chief Executive Officer May 31 Buy 1.47 7,656 11,254 7,656 06/08/22